Form 990 for tax year 2022

Revenue

Part VIII, the statement of revenue.

• 1d · Related organizations

  $423,549

• 1f · All other contributions, gifts and grants

  $13,659

• 2a · Program service revenue: PATIENT SERVICE REVENUE

  total $702,333,384 · related or exempt $702,333,384

• 2b · Program service revenue: ANCILLARY REVENUE

  total $2,739,386 · related or exempt $2,568,583 · unrelated business $170,803

• 3 · Investment income

  total $508,969 · excluded $508,969

• 7b · Less cost or other basis and sales expenses

  other assets $316,137

• 7c · Gain or loss

  other assets -$316,137

• 7d · Net gain or loss

  total -$316,137 · excluded -$316,137

• 11a · Other revenue: CAFETERIA & VENDING INCOME

  total $2,161,773 · excluded $2,161,773

• 11b · Other revenue: MISCELLANEOUS REVENUE

  total $1,893,339 · excluded $1,893,339

• 11c · Other revenue: PHARMACY REVENUE

  total $60,654 · excluded $60,654

• 11d · All other revenue

  total $39,832 · excluded $39,832

• 11e · Other revenue, total

  $4,155,598

Functional expenses

Part IX, the statement of functional expenses.

• 1 · Grants to domestic organizations and governments

  total $1,200,317 · program services $1,200,317

• 2 · Grants to domestic individuals

  total $260 · program services $260

• 5 · Compensation of officers, directors and key employees

  total $4,896,754 · management and general $4,896,754

• 7 · Other salaries and wages

  total $232,847,118 · program services $213,547,337 · management and general $19,299,781

• 8 · Pension plan contributions

  total $7,978,506 · program services $7,166,488 · management and general $812,018

• 9 · Other employee benefits

  total $29,681,943 · program services $26,661,044 · management and general $3,020,899

• 10 · Payroll taxes

  total $15,505,346 · program services $13,927,279 · management and general $1,578,067

• 11a · Fees: management

  total $1,115,616 · program services $1,115,616

• 11b · Fees: legal

  total $820,533 · management and general $820,533

• 11c · Fees: accounting

  total $207,000 · management and general $207,000

• 11d · Fees: lobbying

  total $28,000 · management and general $28,000

• 11f · Fees: investment management

  total $23 · management and general $23

• 11g · Fees: other

  total $100,666,560 · program services $96,530,151 · management and general $4,136,409

• 12 · Advertising and promotion

  total $2,215,810 · program services $490,970 · management and general $1,724,840

• 13 · Office expenses

  total $5,850,764 · program services $4,425,054 · management and general $1,425,710

• 14 · Information technology

  total $3,160,721 · program services $3,160,721

• 16 · Occupancy

  total $7,104,879 · program services $7,104,879

• 17 · Travel

  total $128,503 · program services $75,147 · management and general $53,356

• 19 · Conferences, conventions and meetings

  total $553,327 · program services $276,200 · management and general $277,127

• 20 · Interest

  total $7,947,826 · program services $7,947,826

• 22 · Depreciation, depletion and amortization

  total $38,582,724 · program services $38,582,724

• 23 · Insurance

  total $2,281,503 · program services $2,281,503

• 24a · Other expenses: MEDICAL SUPPLIES

  total $112,780,454 · program services $112,780,454

• 24b · Other expenses: UBI TAX

  total $77,576 · management and general $77,576

• 24c · Other expenses: BAD DEBT

  total $60,862,433 · program services $60,862,433

• 24d · Other expenses: MEDICAID ASSESSMENT FEE

  total $7,604,111 · program services $7,604,111

• 24e · All other expenses

  total $6,693,696 · program services $6,565,955 · management and general $127,741

Balance sheet

Part X, book values.

• 1 · Cash, non-interest-bearing

  beginning of year $1 · end of year $5

• 4 · Accounts receivable

  beginning of year $64,795,343 · end of year $83,316,902

• 8 · Inventories for sale or use

  beginning of year $11,497,614 · end of year $12,723,915

• 9 · Prepaid expenses and deferred charges

  beginning of year $7,185,216 · end of year $5,054,592

• 10a · Land, buildings and equipment: cost or other basis

  $1,069,817,651

• 10b · Land, buildings and equipment: accumulated depreciation

  $447,508,007

• 10c · Land, buildings and equipment, net

  beginning of year $461,851,798 · end of year $622,309,644

• 11 · Investments: publicly traded securities

  beginning of year $72,361,185 · end of year $18,663,032

• 15 · Other assets

  beginning of year $113,159,509 · end of year $96,374,006

• 17 · Accounts payable and accrued expenses

  beginning of year $145,635,796 · end of year $132,406,624

• 20 · Tax-exempt bond liabilities

  beginning of year $263,486,757 · end of year $250,284,717

• 25 · Other liabilities

  beginning of year $97,594,899 · end of year $61,289,914

• 27 · Net assets without donor restrictions

  beginning of year $127,925,123 · end of year $339,071,374

• 28 · Net assets with donor restrictions

  beginning of year $96,208,091 · end of year $55,389,467

The filer's explanations (Part III)

PART I, LINE 1A

THE ORGANIZATION HAS A POLICY TO ADDRESS WHEN SPOUSAL TRAVEL IS PERMITTED AND PAYS CLUB DUES FOR THE PRESIDENT/CEO FOR BUSINESS PURPOSES AS PART OF THE EMPLOYMENT CONTRACT.

PART I, LINE 4B

THE FOLLOWING INDIVIDUALS RECEIVED DEFERRED COMPENSATION ALLOCATIONS FROM THE FILING ORGANIZATION FROM A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (SERP): DAVID O'CONNOR - $ 111,541 TODD DAVIS, MD - $ 123,431 K. CHRISTOPHER PEEK - $ 223,809 LEIGH HICKMAN - $ 55,268 DANNY WHARTON - $ 80,141 GEORGE ADCOCK III - $ 59,779 ROBIN LANG - $ 53,595 FRANK D. MURPHY - $ 54,811 ASHLEY LONG - $ 30,070

PART I, LINE 6

EXECUTIVE INCENTIVE COMPENSATION PLAN FOR ALL KEY EMPLOYEES BASED ON THE ACHIEVEMENT OF ANNUAL BUSINESS OBJECTIVES WHICH INCLUDE A FINANCIAL GOAL ATTRIBUTABLE TO OPERATING MARGIN. MANAGER INCENTIVE PLAN BASED ON CONSOLIDATED CORPORATE AND INDIVIDUAL PERFORMANCE GOALS. CERTAIN CAROMONT MEDICAL GROUP, INC. PHYSICIAN'S COMPENSATION PACKAGES ARE BASED ON THE INDIVIDUAL PHYSICIANS NET RESULTS FROM OPERATIONS AS CALCULATED BASED SOLELY ON HIS/HER NET CHARGES LESS HIS/HER ALLOCABLE SHARE OF CLINIC OVERHEAD COSTS.